Torisel News
Most Popular Torisel Story
Torisel - 2007 FDA approvals
Drug: Torisel (temsirolimus) Indication: Renal cell carcinoma Company: Wyeth Approval Date: May 30, 2007 Scoop: Torisel is an mTOR inhibitor. In in vitro studies using cancer cells, mTOR inhibition Read more...
Latest Headlines
- February 28, 2008
- January 9, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
